Cargando…

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats

Introduction: There are several pathologic mechanisms involved in diabetic nephropathy, but the role of oxidative stress seems to be one of the most important. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antidiabetic drugs that might also have some other effects i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yaribeygi, Habib, Hemmati, Mohammad Amin, Nasimi, Fatemeh, Maleki, Mina, Jamialahmadi, Tannaz, Reiner, Ivan, Reiner, Željko, Sahebkar, Amirhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253510/ https://www.ncbi.nlm.nih.gov/pubmed/37298010 http://dx.doi.org/10.3390/jcm12113815

Ejemplares similares

Sodium-glucose cotransporter 2 inhibitors and mitochondrial functions: state of the art
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders
por: Yaribeygi, Habib, et al.
Publicado: (2023)

Mechanistic View on the Effects of SGLT2 Inhibitors on Lipid Metabolism in Diabetic Milieu
por: Yaribeygi, Habib, et al.
Publicado: (2022)

Molecular Mechanisms by Which Imeglimin Improves Glucose Homeostasis
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Impact of Incretin-Based Medications on Lipid Metabolism
por: Yaribeygi, Habib, et al.
Publicado: (2021)

Molecular mechanisms linking stress and insulin resistance
por: Yaribeygi, Habib, et al.
Publicado: (2022)

Brain insulin signaling and cognition: Possible links
por: Yaribeygi, Habib, et al.
Publicado: (2023)

The Impact of Diabetes Mellitus in COVID-19: A Mechanistic Review of Molecular Interactions
por: Yaribeygi, Habib, et al.
Publicado: (2020)

Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Effect of Bariatric Surgery on Circulating Levels of Monocyte Chemoattractant Protein-1: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
por: Nomani, Homa, et al.
Publicado: (2021)

Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021)

The Effects of Statin Treatment on Serum Ferritin Levels: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

The Effects of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptydilpeptidase-4 Inhibitors on Blood Pressure and Cardiovascular Complications in Diabetes
por: Yaribeygi, Habib, et al.
Publicado: (2021)

The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jamialahmadi, Tannaz, et al.
Publicado: (2021)

High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome
por: Butler, Alexandra E., et al.
Publicado: (2023)

HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
por: Butler, Alexandra E., et al.
Publicado: (2023)

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin
por: Sanon, Vani P, et al.
Publicado: (2017)

The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling
por: Sokolov, Victor, et al.
Publicado: (2020)

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis
por: Reiner, Željko, et al.
Publicado: (2019)

Statins and the COVID-19 main protease: in silico evidence on direct interaction
por: Reiner, Željko, et al.
Publicado: (2020)

Is there any association between plasma lipid profile and severity of COVID-19?
por: Rahimibashar, Farshid, et al.
Publicado: (2022)

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin
por: Philippaert, Koenraad, et al.
Publicado: (2021)

The Effect of Bariatric Surgery on Circulating Levels of Oxidized Low-Density Lipoproteins Is Apparently Independent of Changes in Body Mass Index: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2021)

Effect of Bariatric Surgery on Intima Media Thickness: A Systematic Review and Meta-Analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Association of Serum PCSK9 Levels with Antibiotic Resistance and Severity of Disease in Patients with Bacterial Infections Admitted to Intensive Care Units
por: Jamialahmadi, Tannaz, et al.
Publicado: (2019)

The Effect of Bariatric Surgery on Circulating Levels of Lipoprotein (a): A Meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Impacts of Sodium/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis
por: Akbari, Abolfazl, et al.
Publicado: (2022)

The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021)

Effects of the sodium‐glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure
por: Kolwelter, Julie, et al.
Publicado: (2021)

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Kandelouei, Tahmineh, et al.
Publicado: (2022)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients
por: Wang, Dong-Dong, et al.
Publicado: (2022)

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study
por: Ring, Arne, et al.
Publicado: (2013)

Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
por: Boutros, Heidi, et al.
Publicado: (2021)

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
por: Moosavian, Seyedeh Alia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7s8kgjvpb2ose0dilgihqshmrk